Lobbying Relationship

Client

Shire Pharmaceuticals LLC

More records

Lobbying firm

STANTON PARK GROUP

More records

  • H.R. 1628, American Healthcare Act of 2017. access to rare and orphan disease therapeutics; newborn screening for heritable disorders; issues impacting pharmaceutical development approval and reimbursement; reauthorization of the prescription drug user fee agreement (PDUFA); CHIP reauthorization orphan drug provisions of HR 1, the American Tax Cuts and Jobs Act

Duration: to

General Issues: Health Issues

Spending: about $480,000 (But it's complicated. Here's why.)

Agencies lobbied since 2015: U.S. Senate, House of Representatives

Bills mentioned

H.R.1628: American Health Care Act of 2017

Sponsor: Diane Black (R-Tenn.)

H.R.909: Andrea Sloan CURE Act

Sponsor: Michael McCaul (R-Texas)

H.R.6: 21st Century Cures Act

Sponsor: Fred Upton (R-Mich.)

S.1878: Advancing Hope Act of 2016

Sponsor: Bob Casey (D-Pa.)

H.R.1537: Advancing Hope Act of 2015

Sponsor: G. K. Butterfield (D-N.C.)

H.R.1: An Act to provide for reconciliation pursuant to titles II and V of the...

Sponsor: Kevin Brady (R-Texas)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
James "J.D." Derderian CoS, House Commerce Committee, Policy Advisor, Rep. Bliley
Erin Strawn Advisor, Rep. Curt Weldon and Rep. Cunningham
Valerie Henry Advisor to Rep. Walden, Senators Warner and Crapo
Emily Shetty Advisor to Rep. Towns, Counsel to House OGR
Richard Russell CoS Senate Commerce, Pro Staff House Science COS, Assoc Director EOP, OSTP Ambassador to World Radiocommunication Conference Sen Dir for Tech/Telecom, Natl Economic Council
Sarah Hamlett Legislative Director, Rep. Thelma Drake; Legislative Assistant, Rep. Schrock
James Derderian n/a
Joseph Rachinsky n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page